Service de Médecine Nucléaire, Hôpital Central
Nancy, France
NCT Number: NCT02858167
The purpose of this study is to define a reference population for FDG-PET neurological examinations starting from patients having FDG-PET to supervise a non-complicated lymphoma (tumor in remission, low disabling chronic tumor).
Looking for future studies?
Notify Me21 year–80 year
All sexes
Interventional
Not applicable
Nancy, France
This study will also check normality of cerebral functions in this population and analyse the influence of various variation factors, such as age, sex ratio, education level, professional activity and neuropsychological test results on normal data.
This database could be later used as comparison to patient images defining the gravity and localization of their cerebral functional disorders.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
FDG injection followed by cerebral examination with X ray spiral CT after 40 minutes and FDG-PET after 60 minutes
Time frame: Day 0
Time frame: Day 0
Time frame: Day 0
Time frame: Day 0
Time frame: Day 0
Time frame: Day 0
Time frame: Day 0
Time frame: Day 0
Evaluation of the normality of cerebral function in study population
Time frame: Day 0
Voxel-based analysis with SPM software of PET data
Time frame: Day 0
Automatic measurement of FDG mean fixation in cerebral sections with NeurogamTM (Segami) software in PET data
Central Hospital, Nancy, France
Other
Creation of a Normal Database for FluoroDeoxyGlucose-Positron Emission Tomography (FDG-PET) Neurological Examinations: Study of Principal Inter-individual Variation Factors
Acronym: BDD TEP FDG
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03480360
Acute Myeloid Leukemia, Anemia
Lebanon, New Hampshire, United States
View Trial DetailsNCT01563874
Hemic and Lymphatic Diseases, Immune System Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT04837222
Hemic and Lymphatic Diseases, Immune System Diseases
Hefei, Anhui, China
View Trial DetailsNCT04737265
Breast Cancer, Breast Diseases
Duarte, California, United States
View Trial Details